Country: Perancis
Bahasa: Inggeris
Sumber: HMA (Heads of Medicines Agencies)
buserelin 4 µg/ml
aniMedica GmbH
QH01CA90
Solution for injection
buserelin
Cattle Females, Horses Females, Rabbit Females
2009-07-29
1. NAME OF THE VETERINARY MEDICINAL PRODUCT Buserelin aniMedica 0,004 mg/ml – Injektionslösung für Rinder, Pferde, Kaninchen (Germany) Buserelin aniMedica 0.004 mg/ml – Injektionslösung für Rinder, Pferde, Kaninchen (Austria) Buserelin aniMedica 0.004 mg/ml – Roztwór do wstrzykiwań bla bydło, konie, króliki (Poland) Busol – 0.004 mg/ml solution injectable pour bovines, equines, lapins (France) Busol – 0.004 mg/ml solution for injection for cattle, horses, rabbits (United Kingdom) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE: 0.0042 mg/ml Buserelin acetate equivalent to 0.004 mg/ml Buserelin EXCIPIENT(S): Benzyl alcohol 20.0 mg/ml For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle, horse, rabbit 4.2 INDICATIONS FOR USE SPECIFYING THE TARGET SPECIES In cattle: - Early cycle induction post partum - Treatment of follicular cysts - Improvement of conception rate in artificial insemination procedures, also after synchronisation of oestrus with a PGF2α analogue. Results may however vary depending on breeding conditions. In horses : - Induction of ovulation to synchronise ovulation more closely with mating - Improvement of conception rate In rabbits: - Improvement of conception rate - Induction of ovulation in post partum insemination. _ _ 4.3 CONTRAINDICATIONS None. 4.4 SPECIAL WARNINGS Treatment with a GnRH analogue is only symptomatic; the causes underlying a fertility disorder are not eliminated by this treatment. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FO Baca dokumen lengkap